In NSCLC patients, high 18F-FDG uptake rates correlate with increased immunohistochemical expression of the glucose transporter 1 (GLUT-1) and upregulation of the rate-determining glycolytic enzyme hexokinase 1 17. The gene discussed is HK1; the disease is non-small cell lung carcinoma.